ENVOY MEDICAL INC (COCH) Stock Price & Overview

NASDAQ:COCH • US29415V1098

Current stock price

0.7475 USD
+0.04 (+6.03%)
At close:
0.7624 USD
+0.01 (+1.99%)
After Hours:

The current stock price of COCH is 0.7475 USD. Today COCH is up by 6.03%. In the past month the price increased by 7.8%. In the past year, price decreased by -47.36%.

COCH Key Statistics

52-Week Range0.3625 - 1.91
Current COCH stock price positioned within its 52-week range.
1-Month Range0.62 - 0.9539
Current COCH stock price positioned within its 1-month range.
Market Cap
21.625M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.41
Dividend Yield
N/A

COCH Stock Performance

Today
+6.03%
1 Week
+7.86%
1 Month
+7.80%
3 Months
+7.45%
Longer-term
6 Months -8.17%
1 Year -47.36%
2 Years -82.41%
3 Years N/A
5 Years N/A
10 Years N/A

COCH Stock Chart

ENVOY MEDICAL INC / COCH Daily stock chart

COCH Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to COCH. When comparing the yearly performance of all stocks, COCH is a bad performer in the overall market: 85.64% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

COCH Earnings

On November 10, 2025 COCH reported an EPS of -0.34 and a revenue of 42.00K. The company missed EPS expectations (-7.53% surprise) and missed revenue expectations (-41.18% surprise).

Next Earnings DateApr 7, 2026
Last Earnings DateNov 10, 2025
PeriodQ3 / 2025
EPS Reported-$0.34
Revenue Reported42K
EPS Surprise -7.53%
Revenue Surprise -41.18%

COCH Forecast & Estimates

7 analysts have analysed COCH and the average price target is 9.69 USD. This implies a price increase of 1196.32% is expected in the next year compared to the current price of 0.7475.

For the next year, analysts expect an EPS growth of 18.83% and a revenue growth -28.14% for COCH


Analysts
Analysts82.86
Price Target9.69 (1196.32%)
EPS Next Y18.83%
Revenue Next Year-28.14%

COCH Groups

Sector & Classification

COCH Financial Highlights

Over the last trailing twelve months COCH reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -4.44% compared to the year before.


Income Statements
Revenue(TTM)208.00K
Net Income(TTM)-28.61M
Industry RankSector Rank
PM (TTM) N/A
ROA -349.72%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%8.11%
Sales Q2Q%-25%
EPS 1Y (TTM)-4.44%
Revenue 1Y (TTM)-25.18%

COCH Ownership

Ownership
Inst Owners5.18%
Shares28.93M
Float18.05M
Ins Owners37.62%
Short Float %4.46%
Short Ratio0.89

About COCH

Company Profile

COCH logo image Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Company Info

IPO: 2021-03-02

ENVOY MEDICAL INC

4875 White Bear Parkway

White Bear Lake MINNESOTA US

Employees: 42

COCH Company Website

COCH Investor Relations

Phone: 16513618000

ENVOY MEDICAL INC / COCH FAQ

What does COCH do?

Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.


What is the current price of COCH stock?

The current stock price of COCH is 0.7475 USD. The price increased by 6.03% in the last trading session.


What is the dividend status of ENVOY MEDICAL INC?

COCH does not pay a dividend.


How is the ChartMill rating for ENVOY MEDICAL INC?

COCH has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Where is ENVOY MEDICAL INC (COCH) stock traded?

COCH stock is listed on the Nasdaq exchange.


How many employees does ENVOY MEDICAL INC have?

ENVOY MEDICAL INC (COCH) currently has 42 employees.


When does ENVOY MEDICAL INC (COCH) report earnings?

ENVOY MEDICAL INC (COCH) will report earnings on 2026-04-07, after the market close.